[Featured Stock] Cha Vaccine Institute Soars 25% on First Day of Listing

[Asia Economy Reporter Ji Yeon-jin] Cha Vaccine Institute's stock price surged nearly 25% on its first day of listing on the KOSDAQ market on the 22nd.

As of 10:13 a.m. that day, Cha Vaccine Institute was trading at 14,550 KRW, up 24.36% from the opening price. The opening price was set at 11,700 KRW, which is 6.36% higher than the public offering price of 11,000 KRW.

Cha Vaccine Institute raised 228.9 billion KRW in subscription deposits from public investors during the public offering subscription. The subscription competition rate was 42.1 to 1.

Cha Vaccine Institute is a bio company developing next-generation vaccines and immunotherapeutics using its self-developed immune enhancement platform technology. An immune enhancer is a vaccine additive that increases the immune response to vaccine antigens through immune enhancement and antigen delivery functions.